This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2025 Jul 31;393(5):515-518.

doi: 10.1056/NEJMc2508629. Epub 2025 Jul 13.

Phase 2a Study of Baxdrostat in Primary Aldosteronism

Collaborators, Affiliations

Collaborators

SPARK Investigator Group:
Irina Bancos, Adina F Turcu, Ramin Sam, Amir H Hamrahian, Alexander Uihlein, Mickie Cheng, Joshua Joseph, Lawrence Kirschner, Wenyu Huang, Bruce Corser, Anat Ben-Shlomo, Oksana Hamidi, Yuan-Di Halvorsen, William Marshall

Affiliations

¹ University of Michigan, Ann Arbor.
² Harvard Medical School, Boston.
³ Mayo Clinic, Rochester, MN.
⁴ Cedars-Sinai Medical Center, Los Angeles.
⁵ University of Texas Southwestern Medical Center, Dallas.
⁶ Johns Hopkins University, Baltimore.
⁷ Northwestern University Feinberg School of Medicine, Chicago.
⁸ Ohio State University Wexner Medical Center, Columbus.
⁹ University of California, San Francisco, San Francisco.
¹⁰ AstraZeneca, Gaithersburg, MD.
¹¹ AstraZeneca, Gothenburg, Sweden.
¹² Queen Mary University of London, London.

PMID: 40658651
DOI: 10.1056/NEJMc2508629

Free article

Phase 2a Study of Baxdrostat in Primary Aldosteronism

Adina F Turcu et al. N Engl J Med. 2025.

Free article

. 2025 Jul 31;393(5):515-518.

doi: 10.1056/NEJMc2508629. Epub 2025 Jul 13.

Authors

Collaborators

SPARK Investigator Group:
Irina Bancos, Adina F Turcu, Ramin Sam, Amir H Hamrahian, Alexander Uihlein, Mickie Cheng, Joshua Joseph, Lawrence Kirschner, Wenyu Huang, Bruce Corser, Anat Ben-Shlomo, Oksana Hamidi, Yuan-Di Halvorsen, William Marshall

Affiliations

¹ University of Michigan, Ann Arbor.
² Harvard Medical School, Boston.
³ Mayo Clinic, Rochester, MN.
⁴ Cedars-Sinai Medical Center, Los Angeles.
⁵ University of Texas Southwestern Medical Center, Dallas.
⁶ Johns Hopkins University, Baltimore.
⁷ Northwestern University Feinberg School of Medicine, Chicago.
⁸ Ohio State University Wexner Medical Center, Columbus.
⁹ University of California, San Francisco, San Francisco.
¹⁰ AstraZeneca, Gaithersburg, MD.
¹¹ AstraZeneca, Gothenburg, Sweden.
¹² Queen Mary University of London, London.

PMID: 40658651
DOI: 10.1056/NEJMc2508629

No abstract available

PubMed Disclaimer

Comment in

More about the Phase 2a Study of Baxdrostat in Primary Aldosteronism.
Carling T, Scholl UI. Carling T, et al. N Engl J Med. 2025 Oct 16;393(15):1550. doi: 10.1056/NEJMc2512324. N Engl J Med. 2025. PMID: 41092341 No abstract available.
More about the Phase 2a Study of Baxdrostat in Primary Aldosteronism. Reply.
Turcu AF, Freeman MW, Brown MJ. Turcu AF, et al. N Engl J Med. 2025 Oct 16;393(15):1550-1552. doi: 10.1056/NEJMc2512324. N Engl J Med. 2025. PMID: 41092342 No abstract available.

Publication types

Actions

Grants and funding

NA/AstraZeneca

LinkOut - more resources

Full Text Sources